Multiple reaction monitoring of multiple low-abundance transcription factors in whole lung cancer cell lysates

Journal of Proteome Research

Volumn 12, Issue 6, 2013, Pages 2582-2596

  Kim, Jun Seok ^a   Lee, Youngju ^a   Lee, Min Young ^b   Shin, Jihye ^a   Han, Jung Min ^c   Yang, Eun Gyeong ^a   Yu, Myeong Hee ^a   Kim, Sunghoon ^c   Hwang, Daehee ^b   Lee, Cheolju ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

doxorubicin; drug resistance; MRM; TF; transition parameters

Indexed keywords

DOXORUBICIN; MESSENGER RNA; SMAD4 PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR;

ANALYTIC METHOD; ARTICLE; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL LYSATE; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); EPIDERMOID TUMOR; FRACTIONATION; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; ISOTOPE LABELING; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LIMIT OF QUANTITATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MULTIPLE REACTION MONITORING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTOMICS;

EID: 84879356633     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3011414     Document Type: Article

References (75)

1. Yalow, R. S.; Berson, S. A. Immunoassay of endogenous plasma insulin in man J. Clin. Invest. 1960, 39, 1157-75
2. Lequin, R. M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA) Clin. Chem. 2005, 51 (12) 2415-8
3. Engvall, E.; Perlmann, P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G Immunochemistry 1971, 8 (9) 871-4
4. Diamandis, E. P.; Morton, R. C. Time-resolved fluorescence using a europium chelate of 4,7-bis-(chlorosulfophenyl)-1,10-phenanthroline-2,9- dicarboxylic acid (BCPDA). Labeling procedures and applications in immunoassays J. Immunol. Methods 1988, 112 (1) 43-52
5. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics Nature 2003, 422 (6928) 198-207
6. Kang, U. B.; Yeom, J.; Kim, H. J.; Kim, H.; Lee, C. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry J. Proteomics 2012, 75 (10) 3050-62
7. Kang, U. B.; Yeom, J.; Kim, H.; Lee, C. Quantitative analysis of mTRAQ-labeled proteome using full MS scans J. Proteome Res. 2010, 9 (7) 3750-8
8. Yu, M. J.; Pisitkun, T.; Wang, G.; Shen, R. F.; Knepper, M. A. LC-MS/MS analysis of apical and basolateral plasma membranes of rat renal collecting duct cells Mol. Cell. Proteomics 2006, 5 (11) 2131-45
9. Ahn, Y.; Kang, U. B.; Kim, J.; Lee, C. Mining of serum glycoproteins by an indirect approach using cell line secretome Mol. Cells 2010, 29 (2) 123-30
10. Bern, M.; Finney, G.; Hoopmann, M. R.; Merrihew, G.; Toth, M. J.; MacCoss, M. J. Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry Anal. Chem. 2010, 82 (3) 833-41
11. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-88
12. Brun, V.; Dupuis, A.; Adrait, A.; Marcellin, M.; Thomas, D.; Court, M.; Vandenesch, F.; Garin, J. Isotope-labeled protein standards: toward absolute quantitative proteomics Mol. Cell. Proteomics 2007, 6 (12) 2139-49
13. Domon, B.; Aebersold, R. Mass spectrometry and protein analysis Science 2006, 312 (5771) 212-7
14. Picotti, P.; Rinner, O.; Stallmach, R.; Dautel, F.; Farrah, T.; Domon, B.; Wenschuh, H.; Aebersold, R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes Nat. Methods 2010, 7 (1) 43-6
15. Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29 (7) 625-34
16. Wang, Q.; Chaerkady, R.; Wu, J.; Hwang, H. J.; Papadopoulos, N.; Kopelovich, L.; Maitra, A.; Matthaei, H.; Eshleman, J. R.; Hruban, R. H.; Kinzler, K. W.; Pandey, A.; Vogelstein, B. Mutant proteins as cancer-specific biomarkers Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (6) 2444-9
17. Lopez, M. F.; Rezai, T.; Sarracino, D. A.; Prakash, A.; Krastins, B.; Athanas, M.; Singh, R. J.; Barnidge, D. R.; Oran, P.; Borges, C.; Nelson, R. W. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants Clin. Chem. 2010, 56 (2) 281-90
18. Kuzyk, M. A.; Smith, D.; Yang, J. C.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-77
19. Kiyonami, R.; Schoen, A.; Prakash, A.; Peterman, S.; Zabrouskov, V.; Picotti, P.; Aebersold, R.; Huhmer, A.; Domon, B. Increased selectivity, analytical precision, and throughput in targeted proteomics Mol. Cell. Proteomics 2011, 10 (2) M110 002931
20. Maclean, B.; Tomazela, D. M.; Abbatiello, S. E.; Zhang, S.; Whiteaker, J. R.; Paulovich, A. G.; Carr, S. A.; Maccoss, M. J. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry Anal. Chem. 2010, 82 (24) 10116-24
21. American Cancer Society, Cancer Facts & Figures 2011. http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/ cancer-facts-figures-2011 (accessed April 5, 2012).
22. Vigano, M. G.; Cavina, R.; Novello, S.; Grossi, F.; Santoro, A.; Gregorc, V.; Scagliotti, G.; Garassino, I. M.; Rossoni, G.; Levra, M. G.; Genova, C.; Caligaris-Cappio, F.; Lambiase, A.; Bordignon, C. Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC). J. Clin. Oncol. 2011, 29, Suppl; Abstr 7077.
23. University of Nebraska, N. C. I. N., A Phase I Study ofWeekly Doxorubicin and Oral Topotecan for Patients With Relapsed orRefractory Small Cell Lung Cancer (SCLC). http://clinicaltrials.gov/ct2/show/NCT00856037 (accessed April 5, 2012).
24. Gao, Z.; Fields, J. Z.; Boman, B. M. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells Anticancer Res. 1998, 18 (4C) 3073-6
25. Sharma, A.; Patrick, B.; Li, J.; Sharma, R.; Jeyabal, P. V. S.; Reddy, P. M. R. V.; Awasthi, S.; Awasthi, Y. C. Glutathione S-transferases as antioxidant enzymes: Small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis Arch. Biochem. Biophys. 2006, 452 (2) 165-73
26. Hao, X. Y.; Bergh, J.; Brodin, O.; Hellman, U.; Mannervik, B. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes Carcinogenesis 1994, 15 (6) 1167-73
27. Mattern, J.; Volm, M. Increased resistance to doxorubicin in human non-small-cell lung carcinomas with metallothionein expression Int. J. Oncol. 1992, 1 (6) 687-9
28. Beck, M.; Schmidt, A.; Malmstroem, J.; Claassen, M.; Ori, A.; Szymborska, A.; Herzog, F.; Rinner, O.; Ellenberg, J.; Aebersold, R. The quantitative proteome of a human cell line Mol. Syst. Biol. 2011, 7, 549
29. Das, S.; Bosley, A. D.; Ye, X.; Chan, K. C.; Chu, I.; Green, J. E.; Issaq, H. J.; Veenstra, T. D.; Andresson, T. Comparison of strong cation exchange and SDS-PAGE fractionation for analysis of multiprotein complexes J. Proteome Res. 2010, 9 (12) 6696-704
30. Geiger, T.; Clarke, S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation J. Biol. Chem. 1987, 262 (2) 785-94
31. Yang, W. S.; Moon, H. G.; Kim, H. S.; Choi, E. J.; Yu, M. H.; Noh, D. Y.; Lee, C. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer J. Proteome Res. 2012, 11 (2) 1078-88
32. Wagner, K. W.; Punnoose, E. A.; Januario, T.; Lawrence, D. A.; Pitti, R. M.; Lancaster, K.; Lee, D.; von Goetz, M.; Yee, S. F.; Totpal, K.; Huw, L.; Katta, V.; Cavet, G.; Hymowitz, S. G.; Amler, L.; Ashkenazi, A. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nat. Med. 2007, 13 (9) 1070-7
33. Edgar, R.; Domrachev, M.; Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res. 2002, 30 (1) 207-10
34. Walpole, R. E. Probability & Statistics for Engineers & Scientists, 9 th ed.; Prentice Hall: Boston, 2012; p 791.
35. Tse, C.; Shoemaker, A. R.; Adickes, J.; Anderson, M. G.; Chen, J.; Jin, S.; Johnson, E. F.; Marsh, K. C.; Mitten, M. J.; Nimmer, P.; Roberts, L.; Tahir, S. K.; Xiao, Y.; Yang, X.; Zhang, H.; Fesik, S.; Rosenberg, S. H.; Elmore, S. W. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor Cancer Res. 2008, 68 (9) 3421-8
36. Wu, Z. J.; Irizarry, R. A.; Gentleman, R.; Martinez-Murillo, F.; Spencer, F. A model-based background adjustment for oligonucleotide expression arrays J. Am. Stat. Assoc. 2004, 99 (468) 909-17
37. Lee, H. J.; Suk, J. E.; Patrick, C.; Bae, E. J.; Cho, J. H.; Rho, S.; Hwang, D.; Masliah, E.; Lee, S. J. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies J. Biol. Chem. 2010, 285 (12) 9262-72
38. Ekins, S.; Nikolsky, Y.; Bugrim, A.; Kirillov, E.; Nikolskaya, T. Pathway mapping tools for analysis of high content data Methods Mol. Biol. 2007, 356, 319-50
39. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4 (1) 44-57
40. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 2000, 25 (1) 25-9
41. Cline, M. S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2007, 2 (10) 2366-82
42. Ding, L.; Getz, G.; Wheeler, D. A.; Mardis, E. R.; McLellan, M. D.; Cibulskis, K.; Sougnez, C.; Greulich, H.; Muzny, D. M.; Morgan, M. B.; Fulton, L.; Fulton, R. S.; Zhang, Q.; Wendl, M. C.; Lawrence, M. S.; Larson, D. E.; Chen, K.; Dooling, D. J.; Sabo, A.; Hawes, A. C.; Shen, H.; Jhangiani, S. N.; Lewis, L. R.; Hall, O.; Zhu, Y.; Mathew, T.; Ren, Y.; Yao, J.; Scherer, S. E.; Clerc, K.; Metcalf, G. A.; Ng, B.; Milosavljevic, A.; Gonzalez-Garay, M. L.; Osborne, J. R.; Meyer, R.; Shi, X.; Tang, Y.; Koboldt, D. C.; Lin, L.; Abbott, R.; Miner, T. L.; Pohl, C.; Fewell, G.; Haipek, C.; Schmidt, H.; Dunford-Shore, B. H.; Kraja, A.; Crosby, S. D.; Sawyer, C. S.; Vickery, T.; Sander, S.; Robinson, J.; Winckler, W.; Baldwin, J.; Chirieac, L. R.; Dutt, A.; Fennell, T.; Hanna, M.; Johnson, B. E.; Onofrio, R. C.; Thomas, R. K.; Tonon, G.; Weir, B. A.; Zhao, X.; Ziaugra, L.; Zody, M. C.; Giordano, T.; Orringer, M. B.; Roth, J. A.; Spitz, M. R.; Wistuba, I. I.; Ozenberger, B.; Good, P. J.; Chang, A. C.; Beer, D. G.; Watson, M. A.; Ladanyi, M.; Broderick, S.; Yoshizawa, A.; Travis, W. D.; Pao, W.; Province, M. A.; Weinstock, G. M.; Varmus, H. E.; Gabriel, S. B.; Lander, E. S.; Gibbs, R. A.; Meyerson, M.; Wilson, R. K. Somatic mutations affect key pathways in lung adenocarcinoma Nature 2008, 455 (7216) 1069-75
43. Maheswaran, S.; Sequist, L. V.; Nagrath, S.; Ulkus, L.; Brannigan, B.; Collura, C. V.; Inserra, E.; Diederichs, S.; Iafrate, A. J.; Bell, D. W.; Digumarthy, S.; Muzikansky, A.; Irimia, D.; Settleman, J.; Tompkins, R. G.; Lynch, T. J.; Toner, M.; Haber, D. A. Detection of mutations in EGFR in circulating lung-cancer cells N. Engl. J. Med. 2008, 359 (4) 366-77
44. Marks, J. L.; Gong, Y.; Chitale, D.; Golas, B.; McLellan, M. D.; Kasai, Y.; Ding, L.; Mardis, E. R.; Wilson, R. K.; Solit, D.; Levine, R.; Michel, K.; Thomas, R. K.; Rusch, V. W.; Ladanyi, M.; Pao, W. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma Cancer Res. 2008, 68 (14) 5524-8
45. Thomas, R. K.; Baker, A. C.; Debiasi, R. M.; Winckler, W.; Laframboise, T.; Lin, W. M.; Wang, M.; Feng, W.; Zander, T.; MacConaill, L.; Lee, J. C.; Nicoletti, R.; Hatton, C.; Goyette, M.; Girard, L.; Majmudar, K.; Ziaugra, L.; Wong, K. K.; Gabriel, S.; Beroukhim, R.; Peyton, M.; Barretina, J.; Dutt, A.; Emery, C.; Greulich, H.; Shah, K.; Sasaki, H.; Gazdar, A.; Minna, J.; Armstrong, S. A.; Mellinghoff, I. K.; Hodi, F. S.; Dranoff, G.; Mischel, P. S.; Cloughesy, T. F.; Nelson, S. F.; Liau, L. M.; Mertz, K.; Rubin, M. A.; Moch, H.; Loda, M.; Catalona, W.; Fletcher, J.; Signoretti, S.; Kaye, F.; Anderson, K. C.; Demetri, G. D.; Dummer, R.; Wagner, S.; Herlyn, M.; Sellers, W. R.; Meyerson, M.; Garraway, L. A. High-throughput oncogene mutation profiling in human cancer Nat. Genet. 2007, 39 (3) 347-51
46. Yamamoto, H.; Shigematsu, H.; Nomura, M.; Lockwood, W. W.; Sato, M.; Okumura, N.; Soh, J.; Suzuki, M.; Wistuba, I. I.; Fong, K. M.; Lee, H.; Toyooka, S.; Date, H.; Lam, W. L.; Minna, J. D.; Gazdar, A. F. PIK3CA mutations and copy number gains in human lung cancers Cancer Res. 2008, 68 (17) 6913-21
47. Bass, A. J.; Watanabe, H.; Mermel, C. H.; Yu, S.; Perner, S.; Verhaak, R. G.; Kim, S. Y.; Wardwell, L.; Tamayo, P.; Gat-Viks, I.; Ramos, A. H.; Woo, M. S.; Weir, B. A.; Getz, G.; Beroukhim, R.; O'Kelly, M.; Dutt, A.; Rozenblatt-Rosen, O.; Dziunycz, P.; Komisarof, J.; Chirieac, L. R.; Lafargue, C. J.; Scheble, V.; Wilbertz, T.; Ma, C.; Rao, S.; Nakagawa, H.; Stairs, D. B.; Lin, L.; Giordano, T. J.; Wagner, P.; Minna, J. D.; Gazdar, A. F.; Zhu, C. Q.; Brose, M. S.; Cecconello, I., Jr; U., R.; Marie, S. K.; Dahl, O.; Shivdasani, R. A.; Tsao, M. S.; Rubin, M. A.; Wong, K. K.; Regev, A.; Hahn, W. C.; Beer, D. G.; Rustgi, A. K.; Meyerson, M. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Nat. Genet. 2009, 41 (11) 1238-42
48. Kendall, J.; Liu, Q.; Bakleh, A.; Krasnitz, A.; Nguyen, K. C.; Lakshmi, B.; Gerald, W. L.; Powers, S.; Mu, D. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (42) 16663-8
49. Weir, B. A.; Woo, M. S.; Getz, G.; Perner, S.; Ding, L.; Beroukhim, R.; Lin, W. M.; Province, M. A.; Kraja, A.; Johnson, L. A.; Shah, K.; Sato, M.; Thomas, R. K.; Barletta, J. A.; Borecki, I. B.; Broderick, S.; Chang, A. C.; Chiang, D. Y.; Chirieac, L. R.; Cho, J.; Fujii, Y.; Gazdar, A. F.; Giordano, T.; Greulich, H.; Hanna, M.; Johnson, B. E.; Kris, M. G.; Lash, A.; Lin, L.; Lindeman, N.; Mardis, E. R.; McPherson, J. D.; Minna, J. D.; Morgan, M. B.; Nadel, M.; Orringer, M. B.; Osborne, J. R.; Ozenberger, B.; Ramos, A. H.; Robinson, J.; Roth, J. A.; Rusch, V.; Sasaki, H.; Shepherd, F.; Sougnez, C.; Spitz, M. R.; Tsao, M. S.; Twomey, D.; Verhaak, R. G.; Weinstock, G. M.; Wheeler, D. A.; Winckler, W.; Yoshizawa, A.; Yu, S.; Zakowski, M. F.; Zhang, Q.; Beer, D. G.; Wistuba, I. I.; Watson, M. A.; Garraway, L. A.; Ladanyi, M.; Travis, W. D.; Pao, W.; Rubin, M. A.; Gabriel, S. B.; Gibbs, R. A.; Varmus, H. E.; Wilson, R. K.; Lander, E. S.; Meyerson, M. Characterizing the cancer genome in lung adenocarcinoma Nature 2007, 450 (7171) 893-8
50. Rauch, T. A.; Zhong, X.; Wu, X.; Wang, M.; Kernstine, K. H.; Wang, Z.; Riggs, A. D.; Pfeifer, G. P. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (1) 252-7
51. Shames, D. S.; Girard, L.; Gao, B.; Sato, M.; Lewis, C. M.; Shivapurkar, N.; Jiang, A.; Perou, C. M.; Kim, Y. H.; Pollack, J. R.; Fong, K. M.; Lam, C. L.; Wong, M.; Shyr, Y.; Nanda, R.; Olopade, O. I.; Gerald, W.; Euhus, D. M.; Shay, J. W.; Gazdar, A. F.; Minna, J. D. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies PLoS Med. 2006, 3 (12) e486
52. Tsou, J. A.; Hagen, J. A.; Carpenter, C. L.; Laird-Offringa, I. A. DNA methylation analysis: a powerful new tool for lung cancer diagnosis Oncogene 2002, 21 (35) 5450-61
53. SABiosciences, a. Q. c., Functional Gene Grouping, Human Lung Cancer DNA Methylation PCR Array. http://www.sabiosciences.com/dna-methylation-product/ HTML/MEAH-3040A.html#function (accessed April 5, 2012).
54. Beer, D. G.; Kardia, S. L.; Huang, C. C.; Giordano, T. J.; Levin, A. M.; Misek, D. E.; Lin, L.; Chen, G.; Gharib, T. G.; Thomas, D. G.; Lizyness, M. L.; Kuick, R.; Hayasaka, S.; Taylor, J. M.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat. Med. 2002, 8 (8) 816-24
55. Bhattacharjee, A.; Richards, W. G.; Staunton, J.; Li, C.; Monti, S.; Vasa, P.; Ladd, C.; Beheshti, J.; Bueno, R.; Gillette, M.; Loda, M.; Weber, G.; Mark, E. J.; Lander, E. S.; Wong, W.; Johnson, B. E.; Golub, T. R.; Sugarbaker, D. J.; Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc. Natl. Acad. Sci. U. S. A. 2001, 98 (24) 13790-5
56. Garber, M. E.; Troyanskaya, O. G.; Schluens, K.; Petersen, S.; Thaesler, Z.; Pacyna-Gengelbach, M.; van de Rijn, M.; Rosen, G. D.; Perou, C. M.; Whyte, R. I.; Altman, R. B.; Brown, P. O.; Botstein, D.; Petersen, I. Diversity of gene expression in adenocarcinoma of the lung Proc. Natl. Acad. Sci. U. S. A. 2001, 98 (24) 13784-9
57. Jones, M. H.; Virtanen, C.; Honjoh, D.; Miyoshi, T.; Satoh, Y.; Okumura, S.; Nakagawa, K.; Nomura, H.; Ishikawa, Y. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles Lancet 2004, 363 (9411) 775-81
58. Landi, M. T.; Dracheva, T.; Rotunno, M.; Figueroa, J. D.; Liu, H.; Dasgupta, A.; Mann, F. E.; Fukuoka, J.; Hames, M.; Bergen, A. W.; Murphy, S. E.; Yang, P.; Pesatori, A. C.; Consonni, D.; Bertazzi, P. A.; Wacholder, S.; Shih, J. H.; Caporaso, N. E.; Jen, J. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival PLoS One 2008, 3 (2) e1651
59. Zhou, B. B.; Peyton, M.; He, B.; Liu, C.; Girard, L.; Caudler, E.; Lo, Y.; Baribaud, F.; Mikami, I.; Reguart, N.; Yang, G.; Li, Y.; Yao, W.; Vaddi, K.; Gazdar, A. F.; Friedman, S. M.; Jablons, D. M.; Newton, R. C.; Fridman, J. S.; Minna, J. D.; Scherle, P. A. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer Cancer Cell 2006, 10 (1) 39-50
60. Huang, L. J.; Chen, S. X.; Huang, Y.; Luo, W. J.; Jiang, H. H.; Hu, Q. H.; Zhang, P. F.; Yi, H. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer Lung Cancer 2006, 54 (1) 87-94
61. Planque, C.; Kulasingam, V.; Smith, C. R.; Reckamp, K.; Goodglick, L.; Diamandis, E. P. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteomics 2009, 8 (12) 2746-58
62. Rikova, K.; Guo, A.; Zeng, Q.; Possemato, A.; Yu, J.; Haack, H.; Nardone, J.; Lee, K.; Reeves, C.; Li, Y.; Hu, Y.; Tan, Z.; Stokes, M.; Sullivan, L.; Mitchell, J.; Wetzel, R.; Macneill, J.; Ren, J. M.; Yuan, J.; Bakalarski, C. E.; Villen, J.; Kornhauser, J. M.; Smith, B.; Li, D.; Zhou, X.; Gygi, S. P.; Gu, T. L.; Polakiewicz, R. D.; Rush, J.; Comb, M. J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 2007, 131 (6) 1190-203
63. Tian, T.; Hao, J.; Xu, A.; Luo, C.; Liu, C.; Huang, L.; Xiao, X.; He, D. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis Cancer Sci. 2007, 98 (8) 1265-74
64. Tyan, Y. C.; Wu, H. Y.; Lai, W. W.; Su, W. C.; Liao, P. C. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry J. Proteome Res. 2005, 4 (4) 1274-86
65. Xiao, T.; Ying, W.; Li, L.; Hu, Z.; Ma, Y.; Jiao, L.; Ma, J.; Cai, Y.; Lin, D.; Guo, S.; Han, N.; Di, X.; Li, M.; Zhang, D.; Su, K.; Yuan, J.; Zheng, H.; Gao, M.; He, J.; Shi, S.; Li, W.; Xu, N.; Zhang, H.; Liu, Y.; Zhang, K.; Gao, Y.; Qian, X.; Cheng, S. An approach to studying lung cancer-related proteins in human blood Mol. Cell. Proteomics 2005, 4 (10) 1480-6
66. Huillet, C.; Adrait, A.; Lebert, D.; Picard, G.; Trauchessec, M.; Louwagie, M.; Dupuis, A.; Hittinger, L.; Ghaleh, B.; Le Corvoisier, P.; Jaquinod, M.; Garin, J.; Bruley, C.; Brun, V. Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ) and selected reaction monitoring Mol. Cell. Proteomics 2012, 11 (2) M111 008235
67. de Sousa Abreu, R.; Penalva, L. O.; Marcotte, E. M.; Vogel, C. Global signatures of protein and mRNA expression levels Mol. Biosyst. 2009, 5 (12) 1512-26
68. Khodarev, N. N.; Roach, P.; Pitroda, S. P.; Golden, D. W.; Bhayani, M.; Shao, M. Y.; Darga, T. E.; Beveridge, M. G.; Sood, R. F.; Sutton, H. G.; Beckett, M. A.; Mauceri, H. J.; Posner, M. C.; Weichselbaum, R. R. STAT1 pathway mediates amplification of metastatic potential and resistance to therapy PLoS One 2009, 4 (6) e5821
69. Rickardson, L.; Fryknas, M.; Dhar, S.; Lovborg, H.; Gullbo, J.; Rydaker, M.; Nygren, P.; Gustafsson, M. G.; Larsson, R.; Isaksson, A. Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles Br. J. Cancer 2005, 93 (4) 483-92
70. Wang, B.; Hsu, S. H.; Majumder, S.; Kutay, H.; Huang, W.; Jacob, S. T.; Ghoshal, K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 Oncogene 2010, 29 (12) 1787-97
71. Tang, X.; Gao, J. S.; Guan, Y. J.; McLane, K. E.; Yuan, Z. L.; Ramratnam, B.; Chin, Y. E. Acetylation-dependent signal transduction for type I interferon receptor Cell 2007, 131 (1) 93-105
72. Burkard, T. R.; Planyavsky, M.; Kaupe, I.; Breitwieser, F. P.; Burckstummer, T.; Bennett, K. L.; Superti-Furga, G.; Colinge, J. Initial characterization of the human central proteome BMC Syst. Biol. 2011, 5, 17
73. Fonslow, B. R.; Stein, B. D.; Webb, K. J.; Xu, T.; Choi, J.; Park, S. K.; Yates, J. R., 3rd Digestion and depletion of abundant proteins improves proteomic coverage Nat. Methods 2013, 10 (1) 54-6
74. Glatter, T.; Ludwig, C.; Ahrne, E.; Aebersold, R.; Heck, A. J.; Schmidt, A. Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion J. Proteome Res. 2012, 11 (11) 5145-56
75. Dycka, F.; Bobal, P.; Mazanec, K.; Bobalova, J. Rapid and efficient protein enzymatic digestion: an experimental comparison Electrophoresis 2012, 33 (2) 288-95